Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Macrogenics Inc shares valued at $1,083 were sold by Smith Beth Ann on Feb 15 ’25. At $2.56 per share, Smith Beth Ann sold 423 shares. The insider’s holdings dropped to 9,532 shares worth approximately $11247.76 following the completion of this transaction.
As published in a research note from JMP Securities on November 07, 2024, Macrogenics Inc [MGNX] has been rated down from a Mkt outperform to a Mkt perform. Analysts at BTIG Research downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in early August. As of July 31, 2024, Guggenheim has decreased its “Buy” rating to a “Neutral” for MGNX. Earlier on July 31, 2024, B. Riley Securities downgraded its rating. Their new recommendation was “a Neutral” for MGNX stock which previously was a “a Buy”.
Analyzing MGNX Stock Performance
During the last five days, there has been a drop of approximately -7.09%. Over the course of the year, Macrogenics Inc shares have dropped approximately -63.69%. Shares of the company reached a 52-week high of $3.6000 on 01/06/25 and a 52-week low of $0.9900 on 04/07/25. A 50-day SMA is recorded $2.0370, while a 200-day SMA reached $3.2547.
Support And Resistance Levels for Macrogenics Inc (MGNX)
According to the 24-hour chart, there is a support level at 1.0902, which, if violated, would cause prices to drop to 1.0003. In the upper region, resistance lies at 1.2797. The next price resistance is at 1.3793. RSI (Relative Strength Index) is 29.18 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.0295, which suggests the price will decrease in the coming days. Percent R is at 63.46%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
